display ongoing
results: demonstrated suggested inconclusive safety concern ongoing study
metastatic/advanced UC (mUC) - 1st Line (L1)metastatic/advanced UC (mUC) - 2nd Line (L2)muscular invasive bladder cancer (MIBC)
mUC - L1 - all populationmUC - L2 - all populationmUC - L2 - PDL1 positiveMIBC - NA - all population
atezolizumab alone IMvigor-130 ... IMvigor-211 ... IMvigor-211 ... IMvigor-211 ... IMvigor-010

Study type:

 

- About us - Contact us - Method - RSS Made with in Lyon - Credits - Privacy policy - Licence Creative Commons